Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1974 May;9(5):781–787. doi: 10.1128/iai.9.5.781-787.1974

Enhancement of Resistance to Infectious Diseases by Oral Administration of Brewer's Yeast

Yehudith Sinai 1, A Kaplun 1, Y Hai 1, Bilha Halperin 1
PMCID: PMC414885  PMID: 4132909

Abstract

The effect of oral administration of brewer's yeast on resistance to infectious diseases was studied in laboratory animals. It was shown that there was a significantly increased enhancement of resistance to seasonal respiratory and enteric infections in rhesus monkeys. Similarly, enhanced resistance to experimental chronic infections was observed in mice after yeast administration. A 2-week lag occurred between the initiation of yeast treatment and the expression of enhanced resistance. Study of the mechanism of the yeast-induced enhancement of resistance to infection leads to the conclusion that it is based on in vivo stimulation of phagocytosis, as measured by the “phagocytic index.” No effect of brewer's yeast on circulating antibody levels was detected.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BIOZZI G., BENACERRAF B., HALPERN B. N. Quantitative study of the granulopectic activity of the reticulo-endothelial system. II. A study of the kinetics of the R. E. S. in relation to the dose of carbon injected; relationship between the weight of the organs and their activity. Br J Exp Pathol. 1953 Aug;34(4):441–457. [PMC free article] [PubMed] [Google Scholar]
  2. BOYDEN S. V. The adsorption of proteins on erythrocytes treated with tannic acid and subsequent hemagglutination by antiprotein sera. J Exp Med. 1951 Feb;93(2):107–120. doi: 10.1084/jem.93.2.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BURKE J. F., MILES A. A. The sequence of vascular events in early infective inflammation. J Pathol Bacteriol. 1958 Jul;76(1):1–19. [PubMed] [Google Scholar]
  4. COWAN K. M. Interpretation of properdin levels determined by phage neutralization technique. Science. 1958 Oct 3;128(3327):778–779. doi: 10.1126/science.128.3327.778. [DOI] [PubMed] [Google Scholar]
  5. CRUMPTON M. J., DAVIES D. A. An antigenic analysis of Pasteurella pestis by diffusion of antigens and antibodies in agar. Proc R Soc Lond B Biol Sci. 1956 Mar 27;144(918):109–134. doi: 10.1098/rspb.1956.0021. [DOI] [PubMed] [Google Scholar]
  6. ELBERG S. S., FAUNCE K., Jr Immunization against Brucella infection. VI. Immunity conferred on goats by a nondependent mutant from a streptomycin-dependent mutant strain of Brucella melitensis. J Bacteriol. 1957 Feb;73(2):211–217. doi: 10.1128/jb.73.2.211-217.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Glynn A. A., Milne C. M. A kinetic study of the bacteriolytic and bactericidal action of human serum. Immunology. 1967 Jun;12(6):639–653. [PMC free article] [PubMed] [Google Scholar]
  8. Markenson J., Ben-Efraim S. Comportement in vivo des souches de Pasteurella pestis en relation avec leur efficacité comme vaccins vivants. Ann Inst Pasteur (Paris) 1969 Aug;117(2):196–212. [PubMed] [Google Scholar]
  9. Miler I. Specific and non-specific opsonins. Curr Top Microbiol Immunol. 1970;51:63–78. doi: 10.1007/978-3-642-46213-9_3. [DOI] [PubMed] [Google Scholar]
  10. NELSON R. A., Jr An alternative mechanism for the properdin system. J Exp Med. 1958 Oct 1;108(4):515–535. doi: 10.1084/jem.108.4.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Neter E. Endotoxins and the immune response. Curr Top Microbiol Immunol. 1969;47:82–124. doi: 10.1007/978-3-642-46160-6_5. [DOI] [PubMed] [Google Scholar]
  12. PILLEMER L., BLUM L., LEPOW I. H., ROSS O. A., TODD E. W., WARDLAW A. C. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 1954 Aug 20;120(3112):279–285. doi: 10.1126/science.120.3112.279. [DOI] [PubMed] [Google Scholar]
  13. PILLEMER L., ROSS O. A. Alterations in serum properdin levels following injection of Zymosan. Science. 1955 May 20;121(3151):732–733. doi: 10.1126/science.121.3151.732. [DOI] [PubMed] [Google Scholar]
  14. PILLEMER L., SCHOENBERG M. D., BLUM L., WURZ L. Properdin system and immunity. II. Interaction of the properdin system with polysaccharides. Science. 1955 Sep 23;122(3169):545–549. doi: 10.1126/science.122.3169.545. [DOI] [PubMed] [Google Scholar]
  15. SUTER E., RAMSEIAR H. CELLULAR REACTIONS IN INFECTION. Adv Immunol. 1964;27:117–173. doi: 10.1016/s0065-2776(08)60707-5. [DOI] [PubMed] [Google Scholar]
  16. Snyder H. E. Microbial sources of protein. Adv Food Res. 1970;18:85–140. doi: 10.1016/s0065-2628(08)60368-7. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES